Wockhardt Signs Marketing Deal

Wockhardt (Mumbai), one of India’s top pharmaceutical and biotechnology companies, has signed an in-licensing agreement with specialty pharma company Crawford Healthcare (Liverpool, U.K.) to market Viticolor, a skin camouflage gel for vitiligo patients. Vitiligo, otherwise known as leucoderma, is a skin disorder that affects 3%-4% of the Indian population. Wockhardt will manufacture Viticolor in India with imported active ingredients, and Wockhardt’s dermatology team will launch Viticolor on the Indian market in the second quarter. Viticolor is...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers